Read our latest blog: LinkLight™ Protein-Protein Interaction AssaysLearn More

GPCR Assays

GPCR Assay and Profiling Services

Profile G-protein signaling, β-arrestin recruitment, and receptor binding across 80+ GPCR targets

Characterize agonist, antagonist, and biased ligand pharmacology with cAMP, IP1, calcium flux, β-arrestin and 14-3-3, and radioligand binding assays.

How GPCRs Signal and Why It Matters

G protein-coupled receptors (GPCRs) are the largest family of membrane receptors and the target of roughly one-third of approved drugs. Ligand binding activates heterotrimeric G proteins that raise or lower cAMP (Gs, Gi) or trigger IP3 production and calcium release (Gq). Receptor phosphorylation then recruits β-arrestin and 14-3-3, which end G-protein signaling, direct trafficking, and initiate distinct pathways. Ligands can favor one pathway over another, so understanding the complete pharmacology requires measuring multiple pathways.

Reaction Biology supports GPCR drug discovery from assay development through lead optimization. Functional and binding assays can be run individually or combined into pathway profiles, with study design matched to receptor coupling, compound class, and program stage.

Choosing the Right GPCR Assay

Match the readout to receptor coupling and the pharmacological question. Most programs combine a second messenger assay with β-arrestin.

Assay Signaling Event Coupling Detection Best For
Radioligand Binding  Receptor occupancy  Any  Scintillation counting  Affinity, selectivity, off-target 
cAMP  Adenylyl cyclase activity  Gs, Gi  TR-FRET  Gs/Gi potency and efficacy 
IP1  Phospholipase C activity  Gq  TR-FRET  Gq potency, inverse agonism 
Calcium Flux  Calcium mobilization  Gq  Fluorescence (kinetic)  Gq screening, fast kinetics 
β-Arrestin (LinkLight)  Regulatory recruitment  Coupling-independent  Luminescence  Bias, orphans, desensitization 
14-3-3 (LinkLight)  Regulatory recruitment  Coupling-independent  Luminescence  Trafficking, signal duration 

Every Phase of GPCR Signaling

Each assay in our portfolio reads a defined step in the receptor activation sequence. Radioligand binding measures receptor occupancy before any signal is generated. cAMP, IP1, and calcium flux assays quantify immediate G-protein activity for Gs, Gi, and Gq-coupled receptors.  

β-arrestin and 14-3-3 assays capture the regulatory events that follow receptor phosphorylation and control signal duration. Combining these readouts shows where in the cascade a compound acts and whether it favors one pathway over another.

Functional and Binding Assay Formats

cAMP Accumulation

Quantifies Gs and Gi activity through intracellular cAMP levels. Cellular cAMP competes with a labeled cAMP tracer for an anti-cAMP antibody in a TR-FRET competitive immunoassay, so signal decreases as cAMP rises. Gi-coupled activity is read as inhibition of stimulated cAMP production. A cAMP standard curve is used for data normalization.

IP1 Accumulation

Quantifies Gq activity through inositol monophosphate (IP1), the stable downstream metabolite of IP3. Because IP3 degrades within seconds, IP1 provides an accumulated, endpoint-stable measure of phospholipase C activation. Detection uses a TR-FRET competitive immunoassay with an IP1 standard curve for quantitation.

Calcium Flux

Measures intracellular calcium mobilization following Gq-coupled receptor activation on the FLIPR Penta platform. A calcium-sensitive fluorescent dye reports release from intracellular stores in kinetic mode, capturing peak response within seconds of compound addition. The format supports agonist and antagonist screening at high throughput.

β-Arrestin Recruitment

Measures β-arrestin recruitment to the activated receptor using LinkLight cell lines. Recruitment occurs downstream of receptor phosphorylation regardless of G-protein coupling, making this the preferred format for orphan receptors, receptors with mixed coupling, and ligand bias studies. Readout is luminescent and persistent. 

14-3-3 Interaction

Measures recruitment of 14-3-3 scaffold proteins to phosphorylated motifs on the receptor using LinkLight cell lines. 14-3-3 binding influences receptor trafficking, surface expression, and signal duration, providing a regulatory readout that complements β-arrestin and second messenger data. 

Radioligand Binding

Quantifies receptor occupancy through competitive displacement of ³H-labeled reference ligands from human recombinant receptors, detected on a MicroBeta scintillation counter. Binding data establishes affinity independent of functional response and supports selectivity and off-target profiling across receptor families.

Custom Assay Development

For receptors outside the catalog, our GPCR team defines scope and timelines with you, then acquires or generates an appropriate cell line. New assays are qualified to the same standards as catalog assays, and a dedicated project manager provides regular updates at each stage.

Custom Cell Line Generation

Build stable cell lines expressing your GPCR, reporter construct, or custom modification using transfection or lentiviral transduction, including primary and hard-to-transfect cells. Deliverables include a polyclonal pool or validated monoclonal clones with expression QC data, ready for functional assays on our platforms or in your lab.

 

Explore cell line generation services

How LinkLight Cell Lines Work

Platform Advantages

Binding to Function

Radioligand binding, second messenger, and recruitment assays under one provider separate receptor affinity from functional efficacy for the same compound, without reconciling data across vendors.

Every Coupling Class

cAMP, IP1, and calcium flux assays cover Gs, Gi, and Gq-coupled receptors natively, while coupling-independent β-arrestin recruitment extends coverage to orphan and mixed-coupling receptors across 80+ catalog targets.

Consistent Cellular Context

Second messenger and β-arrestin readouts evaluated in the same LinkLight cell line, removing host-cell variables from pathway comparisons and supporting reliable ligand bias assessment.

Transcription-Free Readouts

LinkLight signal is generated by protease cleavage at the moment of interaction, not by downstream reporter gene expression, avoiding transcriptional delay, amplification variability, and off-target pathway effects.

Tagged-Receptor Specificity

Only the TEV-tagged receptor can activate the luciferase reporter, so endogenous receptors and related family members in the host cell cannot generate a recruitment signal.

GPCR Research Applications

  • Ligand Bias Profiling
  • Orphan Receptor Studies
  • Mode of Action and SAR
  • Selectivity and Safety
  • Custom Protein Interactions
Ligand Bias Profiling

Biased ligands preferentially activate G-protein or β-arrestin pathways at the same receptor, an approach pursued to separate therapeutic efficacy from adverse effects. Quantifying bias requires paired concentration-response data from both pathways, ideally in a matched cellular system. LinkLight cell lines support cAMP or calcium assays alongside β-arrestin recruitment in the same cells, with a reference agonist included to calculate bias factors across compound series. 

Orphan Receptor Studies

Orphan and poorly characterized receptors often lack a known G-protein coupling partner, so pathway-specific assays may miss activity entirely. β-arrestin recruitment occurs independently of coupling class, providing a starting readout for ligand discovery and surrogate agonist screening. Parallel cAMP, IP1, and calcium assays then assign coupling. The catalog includes orphan receptors such as GPR3, GPR6, GPR12, GPR55, GPR84, GPR101, GPR119, and GPR141.

Mode of Action and SAR

Agonist, antagonist, inverse agonist, and allosteric modulator activity can be characterized across binding and functional formats to support hit-to-lead and lead optimization. Tracking potency and efficacy shifts in each pathway across an analog series reveals structure-activity relationships that a single readout cannot resolve. All assays are available as single-concentration screens or full concentration-response curves.

Selectivity and Safety

Oncology and immuno-oncology: ADORA2A, ADORA2B, ACKR3, CCR6, C5AR1, PTGER2, PTGER4 

Neuroscience: Dopamine D1 to D5, serotonin 5-HT1A, 5-HT1B, 5-HT2A, 5-HT6, opioid, muscarinic, NTSR1, NPSR1, GALR1, TACR3, GPR3, GPR6, GPR12 

Metabolic disease: GLP1R, GPBAR1, GPR119, FFAR1 to FFAR3, MC4R, GHSR, HCAR2 

Immunology and inflammation: S1P receptors, PTGDR2, GPR84, GPR183, MRGPRX2 

Cardiovascular and renal: APLNR, EDNRA, EDNRB, AVPR1A, ADRB1, P2RY12, BDKRB2 

Bone and endocrine: PTH1R, KISS1R, MC3R

Custom Protein Interactions

LinkLight technology extends beyond GPCRs to any pair of interacting proteins, including membrane receptors with cytoplasmic partners and signaling complexes in intracellular pathways. Protein A is fused to TEV protease and protein B to permuted luciferase, generating a persistent luminescent readout when the pair interacts. Contact our team to scope custom interaction assays and cell line development.

Frequently asked questions

What GPCR assays does Reaction Biology offer?

Reaction Biology offers cAMP, IP1, and calcium flux assays for G-protein signaling; β-arrestin and 14-3-3 recruitment assays for regulatory signaling; and radioligand binding for receptor occupancy. Assays cover Gs, Gi, and Gq-coupled receptors and are available as single-concentration screens, concentration-response curves, or custom development projects.

What is LinkLight, and do I need it for cAMP or calcium assays?

LinkLight is the engineered cell line technology behind most of our GPCR catalog. Each cell line expresses a TEV-tagged receptor and a luciferase-tagged β-arrestin or 14-3-3 partner. The luciferase reporter is only used for recruitment assays. The tagged receptor couples to endogenous G proteins, so cAMP and calcium assays run on the same cells without the reporter.

How do I choose between cAMP, IP1, and calcium flux assays?

Choice depends on receptor coupling. cAMP assays measure Gs activation and Gi inhibition. IP1 and calcium flux both measure Gq activity: calcium flux captures a rapid kinetic response suited to screening, while IP1 accumulates over time and provides a stable endpoint suited to inverse agonist and constitutive activity studies.

Why add β-arrestin data to second messenger assays?

Second messenger assays capture immediate G-protein activation but not the regulatory events that control signal duration and receptor internalization. Biased ligands may show little second messenger activity while strongly recruiting β-arrestin, or the reverse. Second messenger assays can also respond to endogenous receptors in the host cell, while LinkLight recruitment signal requires the tagged receptor.  

What is ligand bias, and how is it measured?

Ligand bias describes a compound that preferentially activates one signaling pathway over another at the same receptor. It is measured by generating concentration-response curves for a G-protein readout and a β-arrestin readout, then comparing potency and efficacy relative to a reference agonist. Running both assays in the same cell line removes cell-background variables from the comparison.  

What is the difference between GPCR binding and functional assays?

Binding assays measure whether and how strongly a compound occupies the receptor, independent of downstream response. Functional assays measure the cellular consequence of binding, distinguishing agonists, antagonists, inverse agonists, and allosteric modulators. Programs typically use binding for affinity and selectivity, and functional assays for mechanism and efficacy. 

Can you test orphan GPCRs?

Yes. β-arrestin recruitment is independent of G-protein coupling, providing a readout for orphan receptors with unknown coupling. The catalog includes multiple orphan receptors, and parallel second messenger assays can be used to assign coupling once activity is detected.

Are your GPCR assays compatible with high-throughput screening?

Yes. cAMP, IP1, and LinkLight assays use homogeneous plate-based formats with standard luminescent or TR-FRET detection, and calcium flux runs in kinetic mode on the FLIPR Penta platform. LinkLight uses economical reagents and a simple luminescent readout, making it cost-effective for large-scale screening.

Can you develop an assay for a GPCR not on your target list?

Yes. Our GPCR team scopes the project with you, acquires or generates a suitable cell line, and qualifies the assay to catalog standards. Custom LinkLight cell lines can be built for β-arrestin, 14-3-3, or other protein interaction partners.